Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

T cells induced by COVID-19 infection respond to new virus variants

T cells induced by COVID-19 infection respond to new virus variants

JULIE STEENHUYSEN  A critical component of the immune system known as T cells that respond to fight infection from the original version of the novel coronavirus appears to also protect against three of the most concerning new virus variants, according to a U.S. laboratory study released. Several recent studies have shown that certain variants of the novel coronavirus can undermine immune protection from antibodies and vaccines. But antibodies - which block the coronavirus from attaching to human cells - may not tell the whole story, according to the study by researchers at the National Institute of Allergy and Infectious Diseases…
Read More
Antibody therapy will likely help against variants

Antibody therapy will likely help against variants

REGENERON Pharmaceuticals Inc's antibody cocktail therapy for COVID-19 will likely also be effective against the new variants of the virus, the drugmaker's chief executive officer has said. Regeneron's antibody therapy received U.S. Food and Drug Administration's authorization for emergency use in mild to moderate COVID-19 patients in November. "We do believe cocktail is very important... having a cocktail makes it more likely we will be able to deal with variants that might pop up," Chief Executive Officer Leonard Schleifer said during J.P. Morgan Health Conference. Regeneron said its cocktail approach has resulted in a treatment that should work against the…
Read More